Document is current
Any future updates will be listed below
-
Authors
Haupenthal, Frederik
Rahn, Jette
Maggi, Fabrizio
Gelas, Fanny
Bourgeois, Philippe
Hugo, Christian
Jilma, Bernd
Böhmig, Georg A.
Herkner, Harald
Wolzt, Michael
Doberer, Konstantin
Vossen, Matthias
Focosi, Daniele
Neuwirt, Hannes
Banas, Miriam
Banas, Bernhard
Budde, Klemens
Viklicky, Ondrej
Malvezzi, Paolo
Rostaing, Lionel
Rotmans, Joris I.
Bakker, Stephan J. L.
Eller, Kathrin
Cejka, Daniel
Pérez, Alberto Molina
Rodriguez-Arias, David
König, Franz
Bond, Gregor https://orcid.org/0000-0003-0440-3053
,
Melzer, Georg
del Alamo, Martha
Beneyto, Isabel
Navarro, David
Ohlmann, Sophie
- License Information
-
More Information
Article History
Received: 6 December 2022
Accepted: 2 March 2023
First Online: 22 March 2023
Declarations
:
: The trial was approved on 04.07.2022 via CTIS for all participating countries. Written informed consent to participate will be obtained from all participants.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: The authors declare the following financial interests/personal relationships which may be considered as a potential competing interest concerning the present work: Fanny Gelas, and Philippe Bourgeois are employees of bioMérieux.
